Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-25 4:20 pm Purchase | 2021-01-20 | 13G | Allena Pharmaceuticals, Inc. ALNAQ | HIRSCHMAN ORIN | 4,000,000 8.000% | 4,000,000 (New Position) | Filing History |
| 2021-01-20 07:20 am Purchase | 2021-01-14 | 13G | Evoke Pharma, Inc. EVOK | HIRSCHMAN ORIN | 11,806 5.300% | 11,806 (New Position) | Filing History |
| 2021-01-19 10:01 am Purchase | 2021-01-15 | 13G | Yield10 Bioscience, Inc. YTEN | HIRSCHMAN ORIN | 12,500 9.000% | 12,500 (New Position) | Filing History |
| 2021-01-12 06:42 am Purchase | 2020-12-31 | 13G | Franklin Wireless Corp. FKWL | HIRSCHMAN ORIN | 780,000 6.800% | 780,000 (New Position) | Filing History |
| 2020-12-28 4:57 pm Sale | 2020-12-23 | 13G | Hepion Pharmaceuticals, Inc. HEPA | HIRSCHMAN ORIN | 58,662 4.000% | -41,339 (-41.34%) | Filing History |
| 2020-12-28 06:11 am Purchase | 2020-12-17 | 13G | LightPath Technologies, Inc. LPTH | HIRSCHMAN ORIN | 1,834,131 7.000% | 1,834,131 (New Position) | Filing History |
| 2020-12-28 06:10 am Purchase | 2020-12-17 | 13G | EMCORE Corporation EMKR | HIRSCHMAN ORIN | 197,901 6.700% | 197,901 (New Position) | Filing History |
| 2020-12-17 08:11 am Purchase | 2020-12-08 | 13G | Cyclo Therapeutics, Inc. CYTH | HIRSCHMAN ORIN | 418,000 9.900% | 418,000 (New Position) | Filing History |
| 2020-12-14 07:15 am Sale | 2020-12-11 | 13G | SELLAS Life Sciences Group, Inc. SLS | HIRSCHMAN ORIN | 190,000 1.500% | -746,735 (-79.72%) | Filing History |
| 2020-12-09 06:49 am Purchase | 2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA | HIRSCHMAN ORIN | 100,000 6.900% | 100,000 (New Position) | Filing History |
| 2020-12-04 06:16 am Purchase | 2020-11-23 | 13G | Myomo, Inc. MYO | HIRSCHMAN ORIN | 416,059 9.100% | 416,059 (New Position) | Filing History |
| 2020-11-27 2:30 pm Purchase | 2020-11-17 | 13G | Aptevo Therapeutics Inc. APVO | HIRSCHMAN ORIN | 75 2.950% | 75 (New Position) | Filing History |
| 2020-11-19 06:44 am Sale | 2020-11-11 | 13G | Everspin Technologies, Inc. MRAM | HIRSCHMAN ORIN | 354,897 11.000% | -595,103 (-62.64%) | Filing History |
| 2020-11-06 07:25 am Purchase | 2020-11-04 | 13G | O2Micro International Limited OIIM | HIRSCHMAN ORIN | 1,828,199 6.800% | 1,828,199 (New Position) | Filing History |
| 2020-09-17 07:43 am Sale | 2020-09-08 | 13G | TETRA Technologies, Inc. TTI | HIRSCHMAN ORIN | 3,563,342 2.830% | -3,194,387 (-47.27%) | Filing History |
| 2020-08-25 09:02 am Purchase | 2020-08-03 | 13G | SELLAS Life Sciences Group, Inc. SLS | HIRSCHMAN ORIN | 936,735 9.900% | 936,735 (New Position) | Filing History |
| 2020-08-06 11:43 am Purchase | 2020-07-22 | 13G | Acer Therapeutics Inc. ACER | HIRSCHMAN ORIN | 982,446 11.000% | 430,406 (+77.97%) | Filing History |
| 2020-07-21 5:17 pm Purchase | 2020-07-21 | 13G | TETRA Technologies, Inc. TTI | HIRSCHMAN ORIN | 6,757,729 5.370% | 6,757,729 (New Position) | Filing History |
| 2020-07-21 08:03 am Purchase | 2020-07-10 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 498,797 7.270% | 175,507 (+54.29%) | Filing History |
| 2020-07-10 4:20 pm Sale | 2020-07-07 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 323,290 4.740% | -191,710 (-37.23%) | Filing History |